Most Kwai Chung Limited: Close of Mandatory Cash Offer, Board Changes, and Shareholding Updates

Key Points from the Joint Announcement

• The mandatory unconditional cash offer for Most Kwai Chung Limited (Stock Code: 1716) made by Brave Steed Legacy Limited has closed as of 4:00 p.m., 23 April 2026.
• Only 0.04% of total shares were tendered in the offer, and the Offeror’s stake increased marginally to approximately 65.1%.
• The public float remains healthy at 33.0%, above the minimum requirement of 25% under the Listing Rules.
• Significant changes to the Board: New executive and independent non-executive directors appointed, and a new Chairman named.
• Potential price-sensitive information includes changes in ownership, Board and committee compositions, and strategic leadership.

Details of the Mandatory Offer and Its Outcome

Brave Steed Legacy Limited (the “Offeror”) made a mandatory unconditional cash offer to acquire all issued shares of Most Kwai Chung Limited not already held by itself and parties acting in concert. The offer closed on 23 April 2026, with only 112,005 shares (approximately 0.04% of issued capital) validly tendered out of 270,000,000 total shares. The offer price was set at HK\$0.6963 per share, resulting in a total consideration of HK\$77,989.08.

Settlement for the validly tendered shares will be completed by 5 May 2026, with payments sent by ordinary post after deducting the Hong Kong seller’s ad valorem stamp duty.

Shareholding Structure Update

Immediately prior to the offer period, Brave Steed Legacy Limited and its concert parties held 65.0% of the company (175,500,000 shares). After the close of the offer, their holding increased slightly to 65.1% (175,612,005 shares). The shareholding of public shareholders increased to 33.0% (89,227,995 shares), ensuring compliance with Listing Rules regarding minimum public float.

Notably, concert parties associated with the Vendor saw their stake decrease from 2.5% to 1.9% due to changes in holding by several staff members.

Changes to the Board & Key Management

• Appointment of Dr. Ma Liyang as Executive Director and Chairman:
  • Dr. Ma, aged 51, brings over a decade of experience in PRC hi-tech environmental protection enterprises and executive roles at listed companies including Kingland Technology Co., Ltd. and Greennovo Environmental Technology Co., Ltd.
  • Holds engineering and business degrees from Tsinghua University and recently completed a doctorate in Engineering in December 2025.
  • Dr. Ma is the sole shareholder and director of Brave Steed Legacy Limited, making him an interested party in 65.1% of the company’s shares.
  • He will serve a three-year term with a director’s fee of HK\$30,000 per annum plus discretionary bonus.
• Appointment of Dr. CHEN Yang as Independent Non-Executive Director:
  • Dr. Chen, aged 47, has over 20 years of investment management experience and holds directorships in several PRC and Hong Kong-listed firms.
  • Educational background includes law and business administration, with a doctorate from Temple University.
  • Dr. Chen will serve a three-year term for a director’s fee of HK\$30,000 per annum plus discretionary bonus and joins the audit, nomination, and remuneration committees.
  • He meets all independence criteria and has no prior connection to the company or its major shareholders.
• Resignation of Mr. Leung Wai Man:
  • Mr. Leung resigned as independent non-executive director and committee member to pursue other commitments. He confirmed no disputes or outstanding issues with the Board.
• Chairmanship Transition:
  • Mr. Iu Kar Ho resigned as Chairman but remains an executive director, with Dr. Ma Liyang assuming the Chairman role effective 23 April 2026.

Key Information for Shareholders and Potential Price-sensitive Events

• Shareholding and Control: The Offeror’s slight increase in stake consolidates control but does not trigger compulsory acquisition or delisting.
• Public Float: The company remains compliant with Listing Rule 13.32B(1), which may allay concerns of forced trading suspension.
• Leadership and Strategy: The appointment of Dr. Ma, with extensive PRC environmental industry experience, as Chairman could signal a strategic shift or new direction, potentially affecting future valuations and investor sentiment.
• Board Stability: New independent non-executive director and committee changes may impact governance and oversight, which is relevant for institutional investors focusing on corporate governance.

Conclusion

This series of developments—culminating in the completion of the mandatory offer, maintenance of public float, and reshuffling of top leadership—represents potentially significant changes for Most Kwai Chung Limited. These may influence the company’s strategic focus, corporate governance, and market perception, and thus could be price sensitive for investors.

Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors are encouraged to consult professional advisors and review the full official documents before making any investment decisions. The reporter and publisher accept no liability for actions taken based on this summary.

View MOST KWAI CHUNG Historical chart here